MENU
NRIX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Nurix Therapeutics (NRIX) Earnings Date & Reports

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders... Show more

A.I. Advisor
published Earnings

NRIX is expected to report earnings to rise 9.22% to -73 cents per share on July 10

Nurix Therapeutics NRIX Stock Earnings Reports
Q2'25
Est.
$-0.73
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.07
Q3'24
Est.
$-0.67
Q2'24
Missed
by $0.08
The last earnings report on April 08 showed earnings per share of -67 cents, beating the estimate of -75 cents. With 784.36K shares outstanding, the current market capitalization sits at 874.42M.
View a ticker or compare two or three
NRIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a biopharmaceutical company, which focuses on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
1700 Owens Street
Phone
+1 415 660-5320
Employees
284
Web
http://www.nurixtx.com